Edward Greeno, MD
Executive Medical Director
Oncology Service Line
This edition of our Provider Update touches on three very timely topics: the role of our oncology outreach team for adult and pediatric cancers; two important clinical trials focused on myelodysplastic syndromes; and research on a new drug to fight oral premalignant lesions.
In the coming months, you will also read more about our new oncology service line. We will talk about the exciting developments and evolution of cancer care at the university and what it means for you and for your patients. Our vision is that the University of Minnesota Physicians and Fairview will be recognized as a national leader in cancer care, focusing on patient experience, clinical outcomes and innovation.
One of our strengths is the pioneering work being done at the university in both basic and translational research, and the integration of that research into clinical practice. In this issue of Provider Update, you will get a glimpse of some of that exciting new research being led by experts here at the University of Minnesota.